The SpinaFX Team
Jeff Cambra
Chief Executive Officer
Medtech executive with over 26 years of commercial experience. Formally Vice President and General Manager of Medtronic’s Interventional Therapies business with expert knowledge of interventional spine procedures, biologics, and devices including Kyphoplasty and Vertebroplasty. His most recent role was Vice President Global reconstruction business at Zimmer Biomet.
Dr. Kieran Murphy
Chief Medical Officer
Professor of Interventional Neuroradiology focused on spine at Toronto Western Hospital. Founded 6 medical device companies, authored 165+ peer-reviewed publications, holds 70 patents, and published several textbooks. Board member and strategic advisor to leading MedTech companies globally. Author of recent definitive paper on Ozone therapy for herniated discs.
Alex Dolgonos
Chief Strategy Officer
Over 30 years of experience in technology and business, with an outstanding track record in commercializing products, strategy development and scaling operations. Founder of DOL Technologies, UROCAM, UBS Inc, Unique Medical Solutions, and investor in others. Alex brings a unique and strategic value mindset to any company.
John Soloninka
PEng, MBA
Chief Technology Officer
Serial Healthtech entrepreneur in Oncology, Radiology, Imaging, eHealth; former Venture Debt CEO overseeing $86M into 36 companies; Former senior health strategist in IBM and Price Waterhouse, and former Research and Commercialization leadership Board Member for the Ontario Brain Institute and Rotman Research Institute.
Medical Advisors
Prof. Mario Muto, MD
Prof. Mario Muto MD, Past President of the European Soc. of Neuroradiology, co inventor developer of Ozone therapy for disc herniations. He has personally treated over 5000 patients at the University of Naples Italy. Author of more than 20 papers on the mechanism of action and inclusion criteria of Ozone therapy in the spine.
Prof. Alexis Kelekis, PhD
Division of Radiology/ Radiotherapy, National and Kapodistrian University of Athens. Alexis does research in Radiology, Orthopedic Surgery and Neuroradiology, is the President of GRIBOI Society, Member of the Board for SIO and is actively researching injectable biomaterials for bone lesions, pain management and disc disease. He is a leader in the 'Prospective Randomized Trial between Percutaneous Ozone injection and Surgery for disc herniation'.
Douglas P.Beall, MD
Dr. Douglas Beall is Chief of Operations of The Spine Fracture Institute, LLC and Chief of Radiology Services at Clinical Radiology of Oklahoma, both located in Oklahoma City, OK. In addition to expertise in Musculoskeletal Imaging and Interventional Spine Care, Dr. Beall is a Diplomate of the American Academy of Pain Management.
Dr. Olivier Clerk, MD
Dr. Clerk is a radiologist and fellowship-trained interventional radiologist in Calgary with a wide array of experience in both interventional pain management and diagnostic imaging. My research evaluates injectables to treat osteoporotic vertebral compression fracture's as well as novel injectables to treat pain generators related to disc degeneration or disc herniation.